New Therapeutic Interventions in Airway Inflammatory and Allergic Diseases

Author(s): M. Ennis

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents

Volume 5 , Issue 4 , 2006

Become EABM
Become Reviewer
Call for Editor


Asthma is a common, chronic condition that is usually treated by the combination of inhaled steroids and β2 agonists on a when required basis. More recently, two further agents have been licensed for use: leukotriene receptor antagonists and very recently anti-IgE. This review describes a number of other possible treatment modalities. Some are well developed and already in Phase III clinical trials, others involve the use of drugs already on the market for other indications and a number are reasonably speculative.

Keywords: Asthma, treatment, anti-cytokine, statin, anti-IgE, toll-like receptors

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Published on: 01 March, 2012
Page: [353 - 356]
Pages: 4
DOI: 10.2174/187152306778772874
Price: $65

Article Metrics

PDF: 5